Insiders · Profile

Morgan Bradley Paul

SVP Drug Discovery & Early Dev at CYTOKINETICS. Filing since 31 Aug 2017. CIK 0001659025

Company
Date
Role
Action
Shares
Amount
Of holding
31 Aug 2017
SVP Drug Discovery & Early Dev
Sold, plan not stated
118,330
$1.77M
71.8%
1 decision on file.